Structural diversity of heparan sulfate binding domains in chemokines - Wikidata - awgldk - TriplyDB

Structural diversity of heparan sulfate binding domains in chemokines

Structural diversity of heparan sulfate binding domains in chemokines

http://www.wikidata.org/entity/Q34008721

about

Polymerization of MIP-1 chemokine (CCL3 and CCL4) and clearance of MIP-1 by insulin-degrading enzyme.Structural basis of chemokine sequestration by CrmD, a poxvirus-encoded tumor necrosis factor receptor Functional aspects of the interaction between interleukin-8 and sulfated glycosaminoglycans On, around, and through: neutrophil-endothelial interactions in innate immunity Integrins are Mechanosensors That Modulate Human Eosinophil Activation.Selectivity in glycosaminoglycan binding dictates the distribution and diffusion of fibroblast growth factors in the pericellular matrix.Dual GPCR and GAG mimicry by the M3 chemokine decoy receptor Structure of mouse IP-10, a chemokine Alternative C-Terminal Helix Orientation Alters Chemokine Function: STRUCTURE OF THE ANTI-ANGIOGENIC CHEMOKINE, CXCL4L1 A Model of GAG/MIP-2/CXCR2 Interfaces and Its Functional Effects Nebulized hypertonic saline decreases IL-8 in sputum of patients with cystic fibrosis Fucoidan as a marine anticancer agent in preclinical development Endothelial heparan sulfate controls chemokine presentation in recruitment of lymphocytes and dendritic cells to lymph nodes Fell-Muir Lecture: Heparan sulphate and the art of cell regulation: a polymer chain conducts the protein orchestra.Profiling heparin-chemokine interactions using synthetic tools The novel CXCL12gamma isoform encodes an unstructured cationic domain which regulates bioactivity and interaction with both glycosaminoglycans and CXCR4.Sulfated oligosaccharides (heparin and fucoidan) binding and dimerization of stromal cell-derived factor-1 (SDF-1/CXCL 12) are coupled as evidenced by affinity CE-MS analysis.Identification of heparin-binding sites in proteins by selective labeling.Differential expression of proteoglycans in tissue remodeling and lymphangiogenesis after experimental renal transplantation in rats.A versatile polyacrylamide gel electrophoresis based sulfotransferase assay.Synthetic di-sulfated iduronic acid attenuates asthmatic response by blocking T-cell recruitment to inflammatory sites The antimicrobial activity of CCL28 is dependent on C-terminal positively-charged amino acids.Characterization of the chemokine CXCL11-heparin interaction suggests two different affinities for glycosaminoglycans.Inhibiting the inhibitors: evaluating agents targeting cancer immunosuppression.Heparin and liver heparan sulfate can rescue hepatoma cells from topotecan action.Inhibition of Streptococcus pneumoniae adherence to human epithelial cells in vitro by the probiotic Lactobacillus rhamnosus GG.A comprehensive compositional analysis of heparin/heparan sulfate-derived disaccharides from human serum.Post-transplant renal tubulitis: the recruitment, differentiation and persistence of intra-epithelial T cells.Heparan sulfate proteoglycans.Identification of amino acid residues important for heparan sulfate proteoglycan interaction within variable region 3 of the feline immunodeficiency virus surface glycoprotein.Intermediate heparan sulfate binding during HPV-16 infection in HaCaTs.On-line capillary isoelectric focusing hyphenated to native electrospray ionization mass spectrometry for the characterization of interferon-γ and variants.The monomer-dimer equilibrium and glycosaminoglycan interactions of chemokine CXCL8 regulate tissue-specific neutrophil recruitment.The Interaction of Heparin Tetrasaccharides with Chemokine CCL5 Is Modulated by Sulfation Pattern and pH Cytokines and growth factors cross-link heparan sulfate.CXCL17 is a mucosal chemokine elevated in idiopathic pulmonary fibrosis that exhibits broad antimicrobial activity.Identification of proteoglycans as the APRIL-specific binding partners.Solution NMR characterization of chemokine CXCL8/IL-8 monomer and dimer binding to glycosaminoglycans: structural plasticity mediates differential binding interactions Clinical utilization of chemokines to combat cancer: the double-edged sword.The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization

P2860

Q24304041-B2716A17-D083-4DEF-88D8-C539314162AD Q24321225-B3F81D1D-9423-4FA5-98C2-4B8D42192B5E Q26865592-D7E7CC96-CFDD-4466-B133-BC28243BFC46 Q26866472-720570CB-3011-4F52-969F-D5E83714F78B Q27329718-CDCA14A6-AF62-4DE7-A836-9F6ABA5BFAC8 Q27336444-FDC8696F-CC3C-4BA9-BACC-2E8C7FE593F6 Q27649259-ED7A3658-7F3C-4636-97F7-B9B5FA070188 Q27650864-EACCD3C4-278D-49E1-8B42-AAEDB7D6E5D4 Q27677101-013A9F6E-DCD5-4AC9-8791-166DE9B9BFA0 Q27681101-2C177E84-8610-46EB-B1A3-20052C70A420 Q28305590-0636E248-0755-4A44-BBD0-91DB06AB3E55 Q28397061-338F3FA9-4FEB-4515-B290-39CA9B057ED9 Q30497539-A7F3FB61-C181-4D1F-9808-288AF706E06B Q30568524-D203D007-DC76-4054-8331-F5E7D4EB103E Q30838810-6F2F8F31-9A11-48B0-BECD-7BB537C4A9B6 Q33304448-D6A3EA32-90F5-4AA2-BACE-0CD1C22145B5 Q33370024-1F2C6274-D144-4AE9-BF76-15539B3DAA07 Q33476610-366FBEDB-D069-4C44-BA1E-FC1187CC6DE4 Q33530073-9163A6FF-0D34-41FA-B2A6-FC4C0B952368 Q33530555-3F7F4EE2-B775-4F6C-91D0-1B027917E06E Q33730506-AFFDEA41-BCF8-474B-A0A0-935F9C4459D1 Q33836880-0314C33D-C8DD-4578-A8D0-62F82FC89C4E Q33885243-9899A1D2-F777-4AB4-90E7-158110FE2BEA Q33903025-E64C8B51-5D1F-4D46-9396-293334D44C12 Q34222480-D454A04F-B3C7-474A-9BDA-F2D9050F7226 Q34656904-C816B962-0EBC-446B-99FD-A12636E6B9D3 Q34981189-1746741D-81E2-4FC8-8D02-05B2FEA50825 Q35030793-0D2A2406-2DC1-4119-9E93-620B96B04E79 Q35059448-0D8FDCA2-EDCF-4AB1-8829-7F57BDCBDBC9 Q35077801-43D1605A-19E3-4E4E-AE01-F9D0637EBE82 Q35379573-1417334D-3C60-4156-A47B-0C873FF74FBC Q35435634-38C4F9D9-3595-40D7-AD2C-44A295AFD153 Q35790211-F82F39C6-BE0F-4652-9328-3D6CA63736A6 Q35860612-BA1183FA-8247-4D3E-855D-A5CBBF1E079A Q36011762-552D6758-F4A3-46F5-8427-F13E5AF1FF2A Q36016463-5FF3F64D-4E66-41C9-BA4B-79B85E96A717 Q36403611-90AAAC08-14F5-422D-B105-118D8133515A Q36406803-1BEB260E-D066-4910-A4DA-1988B8349A53 Q36488894-80111ECE-2814-42B2-9159-F48CD601B539 Q36530735-E1AE9D7E-7257-4E53-976A-18483344E524

P2860

Structural diversity of heparan sulfate binding domains in chemokines

http://www.wikidata.org/entity/Q34008721

description

2002 nî lūn-bûn

@nan

2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Structural diversity of heparan sulfate binding domains in chemokines

@ast

Structural diversity of heparan sulfate binding domains in chemokines

@en

Structural diversity of heparan sulfate binding domains in chemokines

@nl

type

label

Structural diversity of heparan sulfate binding domains in chemokines

@ast

Structural diversity of heparan sulfate binding domains in chemokines

@en

Structural diversity of heparan sulfate binding domains in chemokines

@nl

prefLabel

Structural diversity of heparan sulfate binding domains in chemokines

@ast

Structural diversity of heparan sulfate binding domains in chemokines

@en

Structural diversity of heparan sulfate binding domains in chemokines

@nl

P1433

Q34008721-5DA8F6EB-C32F-42C7-8BEB-E1792A064FDC

P1476

Q34008721-88160ABE-39AA-4AF4-9CF0-9ACD2A46C9EE

P2093

Q34008721-23554945-019D-4A57-9123-CE63208CA6E1

P2860

Q34008721-03C2AC3E-67F2-4D09-B6D7-72D49FBEC7DC

Q34008721-0EE764B8-3B43-4602-BBE1-3E198A4E6733

Q34008721-116E7520-B843-48DF-9818-408A463BE187

Q34008721-1393C36E-0B8C-452E-8C5C-85B11975C355

Q34008721-14DE0620-FA34-4616-8829-144412BFC6F4

Q34008721-15B5B2A2-990F-4576-8C33-F7C69BD21689

Q34008721-1CE8581E-C423-4F03-B280-4F501639B7BC

Q34008721-1FCDA4A9-75A0-4BDD-8F43-E2259ACE3C2D

Q34008721-2E744D89-EC07-48B8-8B9E-CAD1EE570E99

Q34008721-3530ED7A-88E5-414A-B11E-9D85D288C234

P304

Q34008721-D7E822D8-2E9C-4A36-94C2-B6AAB075F489

P31

Q34008721-2ECFE0AB-5373-45CD-B70D-25B12196B9BE

P356

Q34008721-887FEC55-E7EA-4734-B9D3-6EEC243101A2

P407

Q34008721-F4243184-6E3D-4282-AE34-10FB2AF0036A

P433

Q34008721-D33F7389-B573-463C-BA40-BC87810846A9

P478

Q34008721-B4543938-1060-4C80-BEBD-E1D30A526DB0

P50

Q34008721-510DBBFD-A188-4273-B502-C263A69A1BDB

Q34008721-BCF37FB5-0AB4-40EF-A64B-77DA464BCFCD

P577

Q34008721-42E9C5AB-EBBA-4F19-8664-632AA734E613

P5875

Q34008721-AE30AE37-F02F-4C1A-93C1-E07BF7EB8E29

P698

Q34008721-04B1E14F-8F57-4492-BAE0-59CCF97E15EC

P932

Q34008721-F260B53A-8B88-4150-BA07-E7BF62219C15

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Structural diversity of heparan sulfate binding domains in chemokines

@en

P2093

Hugues Lortat-Jacob

http://www.w3.org/2001/XMLSchema#string

P2860

The Protein Data Bank

N.m.r. and molecular-modelling studies of the solution conformation of heparin

Receptor-binding conformation of the "ELR" motif of IL-8: X-ray structure of the L5C/H33C variant at 2.35 A resolution

The crystal structure of the chemokine domain of fractalkine shows a novel quaternary arrangement

Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors

The crystal structure of recombinant human neutrophil-activating peptide-2 (M6L) at 1.9-A resolution

Crystal structure of recombinant human platelet factor 4

The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactions

Determination of the three-dimensional structure of CC chemokine monocyte chemoattractant protein 3 by 1H two-dimensional NMR spectroscopy

Crystal structure of chemically synthesized [N33A] stromal cell-derived factor 1alpha, a potent ligand for the HIV-1 "fusin" coreceptor

P304

1229-1234

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.032497699

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

Aurélien Grosdidier

P577

2002-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11529363

http://www.w3.org/2001/XMLSchema#string

P698

11830659

http://www.w3.org/2001/XMLSchema#string

P932

122172

http://www.w3.org/2001/XMLSchema#string